People who can't afford the name-brand drugs have been flocking to compounded versions, which are available at a fraction of ...
A Miami-Dade County woman was arrested for allegedly selling unlicensed weight-loss medications from her beauty business, ...
Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...
Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.
Mounjaro, a tirzepatide drug prescribed for diabetes, could help people without this condition lose 13% of their body weight ...
A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ...
Semaglutide and tirzepatide were the least cost-effective of four obesity drugs examined in a microsimulation model. A multifaceted approach is needed to reduce financial barriers to obesity ...
The 2nd GLP-1-Based Therapeutics Summit returns to tackle the challenges in best-in-class GLP-1 development and indication ...
In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023 in Los Angeles, California.For Maria Rising, managing her health felt like chasing a phantom ...
More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound® As previously ...
As FDA shortages lift, patients and physicians explore new options for continued treatment with compounded GLP-1 medications.
A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results